Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017

Details for Mechanism ID: 13474
Country/Region: Kenya
Year: 2015
Main Partner: Hope Worldwide
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $266,309 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Testing: HIV Testing and Counseling (HVCT) $121,662
Sexual Prevention: Other Sexual Prevention (HVOP) $140,347
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $4,300
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Age/sex: 15-19 Female 2016 2
CARE_CURR Age/sex: 20-24 Female 2016 53
CARE_CURR Age/sex: 20-24 Male 2016 3
CARE_CURR Age/sex: 25-49 Female 2016 182
CARE_CURR Age/sex: 25-49 Male 2016 60
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 300
CARE_CURR Sum of Age/Sex disaggregates 2016 300
CARE_NEW Age/sex: 15-19 Female 2016 1
CARE_NEW Age/sex: 20-24 Female 2016 14
CARE_NEW Age/sex: 20-24 Male 2016 4
CARE_NEW Age/sex: 25-49 Female 2016 37
CARE_NEW Age/sex: 25-49 Male 2016 19
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 75
CARE_NEW Sum of Age/sex disaggregates 2016 75
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2016 5
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2016 5
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 11,979
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 6,002
HTS_TST By Test Result: Negative 2016 19,811
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 20,278
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 17,981
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 20,278
HTS_TST Sum of Test Result disaggregates 2016 20,278
HTS_TST_POS By Test Result: Positive 2016 467
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 3,776
KP_PREV By key population type: Men who have sex with men/Transgender (MSM/TG) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2016 86
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2016 3,905
TB_ART Female 2016 7
TB_ART Known HIV-positive 2016 8
TB_ART Male 2016 2
TB_ART Sum of Sex disaggregates 2016 9
TB_ART Sum of Test Status disaggregates 2016 8
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 9
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 9
TB_SCREEN Age: 15-19 2016 1
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 300
TB_SCREEN Sex: Female 2016 215
TB_SCREEN Sex: Male 2016 85
TB_SCREEN Sum of Age disaggregates 2016 300
TB_SCREEN Sum of Sex disaggregates 2016 300
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 300
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 270
TX_CURR Sum of age/sex disaggregates 2016 270
TX_NEW By Age/Sex: 15-19 Female 2016 2
TX_NEW By Age/Sex: 15-19 Male 2016 1
TX_NEW By Age/Sex: 20-24 Female 2016 12
TX_NEW By Age/Sex: 20-24 Male 2016 4
TX_NEW By Age/Sex: 25-49 Female 2016 27
TX_NEW By Age/Sex: 25-49 Male 2016 13
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 59
TX_NEW Pregnancy status 2016 1
TX_NEW Sum of Age/Sex disaggregates 2016 59
Cross Cutting Budget Categories and Known Amounts Total: $289,644
Key Populations: MSM and TG $46,650
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Conducting epidemiologic, social science, and operational research among MSM/TG and their sex partners
Monitoring and evaluation of MSM/TG programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for MSM/TG
Key Populations: Sex Workers $202,994
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Monitoring and evaluation of SW programs
Procurement of condoms, lubricants, and other commodities essential to core HIV services for SWs
Gender: Gender Based Violence (GBV) $20,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Post GBV Care
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Gender: Gender Equality $20,000
Changing harmful gender norms and promoting positive gender norms
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation